We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Bioethicists Say Right-to-Try Legislation Will Have Minimal Effect on Drug Access
Bioethicists Say Right-to-Try Legislation Will Have Minimal Effect on Drug Access
Federal right-to-try legislation passed in the Senate and now awaiting a vote in the House would only minimally benefit patient access to investigational drugs and would delay the FDA’s approval process for new drugs, according to bioethicists at the University of Pennsylvania’s Department of Medical Ethics.